intelligent cOmputing Noble Embryo (icONE)
AI-powered Embryo Prediction System
intelligent cOmputing Noble Embryo (icONE)
The current challenges
- 15% of reproductive-aged couples are affected by infertility, which accounts for 168 million people worldwide.
- Overall success rate of In Vitro Fertilization (IVF) procedure is less than 40%.
- Elective single embryo transfer (eSET) is on clinical demand.
Our solution
- icONE integrates both embryo’s genetic big data (PGT-A/niPGT-A) and maternal physical features.
- AI algorithm to predict the pregnant rate of eSET with high accuracy of 92%.
Product features
- FDA Class 1 device listing.
- Cloud-based software as medical device (SaMD).
- Computer-aided diagnosis (CADx).
- Cybersecurity compliance to ISO 27001/ ISO 27018 (Microsoft Azure).
icONE — Accelerator for IVF Journey
Impacts
- The overall prediction accuracy of successful implantation is 92%, which is about 15% higher than any of the current competitors.
- icONE benefits IVF patients by remarkably reducing 80% of the treatment duration and 70% of the overall cost.
- On-site data analysis without requirement of central lab or changes of lab’s original procedures.
Honors and Awards
- 18th National Innovation Award, Taiwan (2021)
- 18th National Innovation Award-Top 7 innovative technology (2021)
- 1st Place of Science and Technological Innovation Pitch Day Competition (2022)
- 1st Place of FITI-Innovation and Entrepreneurship Outstanding Award (2023)
Our team receives award and honor at the National Innovation Award Ceremony.
Our team won the 1st place at Science and Technological Innovation Pitch Day Competition.
Our team won the 1st place of FITI program- Innovation and Entrepreneurship Outstanding Award